CTLA4 and neoplasm: Co-culture of tumor cells and splenocytes derived from mice treated with LRT combined with anti-CTLA4 mAb displayed more cytotoxic T cells and more frequent cytolytic target cells, compared with those from the LRT alone group (Fig. 4D).